News

FDA Approves Bevacizumab Paired with Chemotherapy After Sur...

FDA Approves Bevacizumab Paired with Chemotherapy After Surgery for Advanced Ovarian Cancer

June 29, 2018

(June 29, 2018) Avastin, or bevacizumab, was recently approved by the FDA to be used first with chemotherapy, then by itself, after surgery. A phase III trial studied 1,873 women who had not had any prior treatments for stage III or IV epithelial ovarian, primary peritoneal, or fallopian tube carcinoma. Once the women had undergone … Continued

Research

Meet Sayla, OCRA Advocate Leader

June 26, 2018

Name: Sayla H.Hometown: Portland, ORStatus: In treatmentAdvocacy Goal: Oral Parity, Access to Care Sayla was diagnosed earlier last year and is currently in treatment. She’s determined to use her experience to help other women, and is empowered to advocate for women fighting ovarian cancer through OCRA’s Advocate Leader program. Tell us about your ovarian cancer … Continued

Advocacy

Meet Elise, OCRA Advocate Leader

June 26, 2018

Name: Elise D.Hometown: Durham, NHStatus: 13-Year SurvivorAdvocacy Goal: Access to Care Elise feels lucky that she was diagnosed with early-stage ovarian cancer, and being an Advocate Leader allows her to fight for women who may not be able to fight for themselves. Tell us about your ovarian cancer journey. In the summer of 2005, I … Continued

Advocacy

Join Ovarian Cancer Survivors and Caregivers at OCRFA’...

Join Ovarian Cancer Survivors and Caregivers at OCRFA’s National Conference

June 13, 2018

Over 250 ovarian cancer survivors will travel from across the country to attend OCRFA’s Ovarian Cancer National Conference in Washington DC on July 13-15 Reserve your spot today and join our welcoming community of survivors, caregivers and experts for an inspirational weekend packed with empowering information and new friendships. Registration includes: Fun-filled receptions on Friday … Continued

Events

Super Saturday Moves to September and New York City

Super Saturday Moves to September and New York City

June 11, 2018

(June 11, 2018) OCRFA, who has hosted Super Saturday in the Hamptons for the past 20 years is moving our iconic event to Manhattan. Super September will be held Thursday evening, September 27, and Friday, September 28. According to the New York Post, Page Six, “It’s the end of an era for Super Saturday. The … Continued

Events

OCRFA Awarded 4-Star Rating from Charity Navigator

OCRFA Awarded 4-Star Rating from Charity Navigator

June 6, 2018

(June 6, 2018) OCRFA is pleased to announce we have once again earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. This is the highest rating awarded by Charity Navigator, and demonstrates our steady commitment to responsible fiscal management, and to organizational transparency and accountability, as we continue to strive toward a cure for … Continued

OCRA News

“Ask the Experts” at OCRFA’s Ovarian Canc...

“Ask the Experts” at OCRFA’s Ovarian Cancer National Conference

May 25, 2018

Don’t miss your chance to hear top experts speak at the “Ask the Experts” session at OCRFA’s Ovarian Cancer National Conference. Ask the Experts panelists include: We’ve extended our Ask the Experts Q&A session, giving you more time to learn and more time to answer your questions about ovarian cancer research, science and clinical trials. … Continued

Events

The 2018 American Association for Cancer Research Annual Me...

The 2018 American Association for Cancer Research Annual Meeting

May 18, 2018

(May 18, 2018) Just last month, three of OCRFA’s research advocates attended the 5 day AACR meeting in Chicago, Illinois to learn about new therapies and innovative technology, stay up to date on current projects, and attend lectures from ovarian cancer researchers such as Dr. Anil Sood of MD Anderson and Dr. Dineo Khabele of … Continued

Research

Rebecca’s Journey

Rebecca’s Journey

May 15, 2018

Donate Now It was August of 2001 when I awoke one evening with a stabbing pain in my side that was so serious, I headed straight to the emergency room. I left with a diagnosis of “depression” and a bottle of painkillers. Something inside me – a gut feeling I can’t explain – told me … Continued

Community

Hormone Replacement Therapy After Oophorectomy Is Not Shown...

Hormone Replacement Therapy After Oophorectomy Is Not Shown to Increase Risk of Breast Cancer in BRCA1 Mutation Carriers

May 4, 2018

(May 4, 2018) JAMA Oncology recently published a study that looked at the risk of breast cancer in BRCA1 carriers who underwent a prophylactic bilateral salpingo-oophorectomy, a surgery that removes both ovaries before any sign of disease, followed by hormone replacement therapy (HRT). Eight hundred and seventy two women were followed for around 7.5 years … Continued

Research

OCRFA Funded Study Focuses on the Dissemination of Ovarian ...

OCRFA Funded Study Focuses on the Dissemination of Ovarian Cancer

April 27, 2018

(April 27, 2018) An OCRFA supported study, recently published in Oncogene, delved into the mechanics of how ovarian cancer spreads throughout the body. Researchers at Johns Hopkins, including OCRFA grantee and lead author Ie-Ming Shih, MD, PhD, investigated spleen tyrosine kinase (SYK), which is heavily involved in ovarian cancer tumor progression, in an effort to … Continued

OCRA News

Study Shows Survival Advantage of Primary Cytoreductive Sur...

Study Shows Survival Advantage of Primary Cytoreductive Surgery

April 26, 2018

(April 26, 2018) The International Journal of Gynecological Cancer recently featured a retrospective study on the treatment patterns of women with advanced high-grade serous ovarian carcinoma (HGSC). Of the 852 women with HGSC included in the study, 53% of them underwent primary cytoreductive surgery (PCS), or surgery before chemotherapy to remove as much of the tumor … Continued

Research